Warning
Wells Pharma of Houston LLC Recalls fentaNYL Citrate Injectable Solution in 0
This is a Class II recall. This product may cause temporary health problems or pose a slight threat of a serious nature.
Source: FDA
WarningRecall #D-0508-2026Drug / Pharmaceutical
Wells Pharma of Houston LLC Recalls fentaNYL Citrate Injectable Solution in 0
Wells Pharma of Houston LLC · Class II — Moderate Risk
Product Description
fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 50 mcg/5mL)(10 mcg per mL), wells pharma, NDC 73702-202-15.
Reason for Recall
cGMP deviations.
FDA Classification
Class II — Moderate Risk
A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Distribution
U.S. Nationwide.
Remedy
Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.
Sources: FDA openFDA Enforcement Database